Cellosaurus A549-AC (CVCL_D1JI)
| Cell line name | A549-AC |
|---|---|
| Accession | CVCL_D1JI |
| Resource Identification Initiative | To cite this cell line use: A549-AC (RRID:CVCL_D1JI) |
| Comments | Group: SARS-CoV-2 research cell line. Population: Caucasian. Characteristics: Expresses ACE2 under the control of the EF1a promoter (from parent cell line). Characteristics: Transduced with a EF1a-Cas9-2A-eGFP vector (PubMed=36032971). Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). Genetic integration: Method=Transduction; Gene=HGNC; HGNC:13557; ACE2. Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr. Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9. Omics: Phenotyping; CRISPR screening. Derived from site: In situ; Lung; UBERON=UBERON_0002048. |
| Sequence variations |
|
| Disease | Lung adenocarcinoma (NCIt: C3512) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_A7UV (A549-hACE2 [BEI resources]) |
| Sex of cell | Male |
| Age at sampling | 58Y |
| Category | Cancer cell line |
| Publications | PubMed=36032971; DOI=10.21203/rs.3.rs-1910932/v1; PMCID=PMC9413708 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q127378820 |
| Entry history | |
| Entry creation | 30-Jan-2024 |
| Last entry update | 14-Aug-2025 |
| Version number | 5 |